Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.
This cluster focuses on lifestyle highlights from SCMP's recent reporting, including a historical piece about Consort Wan and her relationship with Emperor Chenghua. It also touches upon the benefits and potential downsides of GLP-1 medications, a topic that has garnered reader interest. AI
Despite Eli Lilly's announcement that its obesity medications will be listed on the formularies of major pharmacy benefit managers, actual coverage remains uncertain. Many health insurers and plan sponsors are reluctant to cover these weight-loss drugs, with some even reducing existing coverage. A Centers for Medicare and Medicaid Services initiative to expand access for seniors and disabled individuals has stalled due to low participation, indicating a general lack of appetite for increased coverage. AI
